G1Therapeutics
AcquiredG1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
Durham, United States · Founded 2008 · $92.5M raised
- Headquarters
- Durham
- Founded
- 2008
- Website
- g1therapeutics.com
- Total Funding
- $92.5M
- Last Round
- $47.0M Series CMay 2016
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Commercial-stage biopharmaceutical company.
Summary
G1Therapeutics is a Biotech company based in Durham, United States, founded in 2008. It has raised $92.5M in total across 3 rounds, most recently a $47.0M Series C round in May 2016. Investors include Eshelman Ventures LLC, MedImmune Ventures and Cormorant Asset Management.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2016
Sign up to see all 3 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/g1therapeutics"><img src="https://indexed.vc/api/badge/company/g1therapeutics" alt="G1Therapeutics on Indexed.vc" width="260" height="76" /></a>